Bromide

Bromide

SCHEMBL8015170

Fc1ccc(C[P+](c2ccccc2)(c2ccccc2)c2ccccc2)cc1F.[Br-]

nearest known ligand 0.51

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHECHKACHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNB1CHRNDCHRNECHRNGHRH2OPRM1

The experimentally established mechanism targets of Bromide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
SNCA P37840 2/20 0.51
HTT P42858 2/20 0.41
HIF1A Q16665 1/20 0.40
KDM1A O60341 1/20 0.39
PIN1 Q13526 1/20 0.36
APP P05067 1/20 0.36
ALDH1A1 P00352 3/20 0.36
MAOB P27338 1/20 0.34
SIGMAR1 Q99720 2/20 0.33
CYP3A4 P08684 1/20 0.33
PDPK1 O15530 1/20 0.33
CYP1A2 P05177 1/20 0.32
CYP2D6 P10635 1/20 0.32
TSHR P16473 1/20 0.32
CYP2C19 P33261 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Bromide SCHEMBL30721146 1.00 SNCA (0.51) SNCAHTTHIF1AKDM1APIN1
Bromide SCHEMBL8030729 0.86 SNCA (0.50) SNCAHTTHIF1AAPPALDH1A1
Bromide SCHEMBL1508860 0.84 SNCA (0.47) SNCAHIF1AAPPSIGMAR1
Bromide SCHEMBL1346296 0.84 SNCA (0.47) SNCAHTTHIF1AKDM1AAPP
Bromide SCHEMBL3534572 0.84 SNCA (0.47) SNCAHIF1AAPPALDH1A1CYP3A4
Bromide SCHEMBL25411424 0.84 SNCA (0.47) SNCAHIF1AAPP
Bromide SCHEMBL1508663 0.84 SNCA (0.47) SNCAHIF1AAPPMAOBCYP3A4
Bromide SCHEMBL6457063 0.83 SNCA (0.49) SNCAHIF1AAPPALDH1A1CYP3A4
Bromide SCHEMBL6909366 0.82 HIF1A (0.47) SNCAHTTHIF1AKDM1AALDH1A1
Bromide SCHEMBL5440664 0.82 SNCA (0.45) SNCA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240199587-A1 HETEROCYCLIC COMPOUNDS HOFFMANN-LA ROCHE INC. (US) 2024-06-20 US disclosed
EP-4326714-A1 HETEROCYCLIC COMPOUNDS F. Hoffmann-La Roche AG (CH) 2024-02-28 EP disclosed
CN-117295726-A Heterocyclic compounds 豪夫迈·罗氏有限公司 2023-12-26 CN disclosed
WO-2022223750-A1 HETEROCYCLIC COMPOUNDS F. HOFFMANN-LA ROCHE AG (CH) 2022-10-27 WO disclosed
EP-0682031-B1 Silacyclohexane-based carbaldehyde compounds and processes for preparing silacyclohexane-based liquid crystal compounds from the carbaldehyde compound SHINETSU CHEMICAL CO (JP) 2000-03-22 EP disclosed
EP-0713878-B1 A method of manufacturing a trans silacyclohexane compound SHINETSU CHEMICAL CO (JP) 2000-02-16 EP disclosed
EP-0692485-B1 Cyclohexane carbaldehyde compounds and processes for preparing silacyclohexane-based liquid crystal compounds from the carbaldehyde compound SHINETSU CHEMICAL CO (JP) 2000-01-05 EP disclosed
US-5560866-A Process for preparing silacyclohexane compounds SHIN-ETSU CHEMICAL CO., LTD. (JP) 1996-10-01 US disclosed
US-5527490-A Silacyclohexane carbaldehyde compounds and processes for preparing silacyclohexane-based liquid crystal compounds from the carbaldehyde compound SHIN-ETSU CHEMICAL CO., LTD. (JP) 1996-06-18 US disclosed
EP-0713878-A1 A method of manufacturing a trans silacyclohexane compound Shin-Etsu Chemical Co., Ltd. (JP) 1996-05-29 EP disclosed
EP-0692485-A1 Cyclohexane carbaldehyde compounds and processes for preparing silacyclohexane-based liquid crystal compounds from the carbaldehyde compound Shin-Etsu Chemical Co., Ltd. (JP) 1996-01-17 EP disclosed
EP-0688776-A2 Process for preparing silacyclo-hexane compounds Shin-Etsu Chemical Co., Ltd. (JP) 1995-12-27 EP disclosed
EP-0682031-A1 Silacyclohexane carbaldehyde compounds and processes for preparing silycyclohexane-based liquid crystal compounds from the carbaldehyde compound SHIN-ETSU CHEMICAL CO., LTD. (JP) 1995-11-15 EP disclosed
US-5185098-A Liquid crystalline mixtures containing 3,4-difluorophenyl-substituted bicyclohexyls HOFFMANN-LA ROCHE INC. (US) 1993-02-09 US disclosed
EP-0220810-B1 INSECTICIDAL ETHERS IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1990-05-02 EP disclosed
US-4788348-A HYDROXY AROMATIC ETHERS AS CHEMICAL INTERMEDIATES IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1988-11-29 US disclosed
US-4705900-A Insecticidal alkenes IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1987-11-10 US disclosed
EP-0220810-A1 Insecticidal ethers IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1987-05-06 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240199587-A1 HETEROCYCLIC COMPOUNDS CYP1B1, CYP1A1, CYP4B1 SNCA 1930/4885HTT 820/4885HIF1A 3094/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.